ORPOF (OSE Immunotherapeutics) Dividends per Share: $0.00 (TTM As of Dec. 2025)

What is OSE Immunotherapeutics Dividends per Share?

OSE Immunotherapeutics ORPOF 41 Dividends per Share is $0.00 as of Dec. 2025. GuruFocus rates ORPOF with a GF Score™ of 41/100 and a GF Value™ of $3.34 (Significantly Overvalued). The stock has 6 warning signs investors should review.

OSE Immunotherapeutics's dividends per share for the six months ended in Dec. 2025 was $0.00. Its dividends per share for the trailing twelve months (TTM) ended in Dec. 2025 was $0.00. Its Dividend Payout Ratio for the six months ended in Dec. 2025 was 0.00. As of today, OSE Immunotherapeutics's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

OSE Immunotherapeutics (OTCPK:ORPOF) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

OSE Immunotherapeutics's Dividend Payout Ratio for the quarter that ended in Dec. 2025 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Dec. 2025 )	/	EPS without NRI (Q: Dec. 2025 )
	=	0	/	-2.751
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OSE Immunotherapeutics Dividends per Share Related Terms

OSE Immunotherapeutics Dividends per Share Historical Data

* Premium members only.

The historical data trend for OSE Immunotherapeutics's Dividends per Share can be seen below:

OSE Immunotherapeutics Dividends per Share Chart

OSE Immunotherapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Dividends per Share

Get a 7-Day Free Trial

0.00

OSE Immunotherapeutics Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
Dividends per Share	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

ORPOF vs VRTX, REGN, ALNY: Dividends per Share Comparison

For the Biotechnology subindustry, OSE Immunotherapeutics's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OSE Immunotherapeutics Dividend Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OSE Immunotherapeutics's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where OSE Immunotherapeutics's Dividend Yield % falls into.

Save Embed

41GF Score

OSE Immunotherapeutics SA ORPOF

Dividends per Share is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

OSE Immunotherapeutics Dividends per Share Calculation

Dividends paid to per common share.

Frequently Asked Questions Learn more about Dividends per Share →

What does a Dividends per Share of $0.00 mean?

OSE Immunotherapeutics (ORPOF) has a Dividends per Share of $0.00 as of Dec. 2025. Dividends per share represents the per-share amount paid as dividends. View historical data on OSE Immunotherapeutics and its competitors.

Is OSE Immunotherapeutics' Dividends per Share too high?

OSE Immunotherapeutics' current Dividends per Share is $0.00. Overall, OSE Immunotherapeutics has a GF Score™ of 41/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does OSE Immunotherapeutics' Dividends per Share compare to VRTX and REGN?

OSE Immunotherapeutics' Dividends per Share of $0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Dividends per Share for a Biotechnology company?

A good Dividends per Share depends on the Biotechnology industry context. However, Dividends per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Dividends per Share mean?

A high Dividends per Share can signal that a stock is expensive relative to its fundamentals. Dividends per share represents the per-share amount paid as dividends. View historical data on OSE Immunotherapeutics and its competitors. OSE Immunotherapeutics's current Dividends per Share is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is OSE Immunotherapeutics stock overvalued right now?

Based on GuruFocus' analysis, OSE Immunotherapeutics (ORPOF) is currently considered Significantly Overvalued. The stock's GF Value™ is $3.34, compared to a current price of $4.43 — trading 32.6% above its estimated fair value. The current Dividends per Share is $0.00. OSE Immunotherapeutics' overall GF Score™ is 41/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Dividends per Share calculated?

Dividends per Share is calculated from a company's financial statements. For OSE Immunotherapeutics (ORPOF), the current Dividends per Share is $0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is OSE Immunotherapeutics (ORPOF) Overvalued in 2026?

Based on GuruFocus' analysis, OSE Immunotherapeutics stock appears to be overvalued. The current stock price of $4.43 is trading 32.6% above its estimated GF Value™ of $3.34. GuruFocus considers OSE Immunotherapeutics to be Significantly Overvalued.

Key valuation signals for ORPOF:

Dividends per Share: $0.00
GF Value™: $3.34 vs. price of $4.43 (32.6% above fair value)
GF Score™: 41/100 with 6 warning signs

No single metric tells the full story. See the ORPOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

OSE Immunotherapeutics Business Description

Industry Healthcare Biotechnology

Comparable Companies XPAR:ADOC XPAR:ABNX XPAR:ALGAE XPAR:ALVIO XPAR:MAAT XPAR:ALTHX XPAR:ALCOX XPAR:MLINA XPAR:ALGEN XPAR:ALSEN VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Other Exchanges 0RAD:UK OSE:France 6OP:Germany

Address 22, Boulevard Benoni Goullin, Nantes, FRA, 44200

Website http://www.ose-immuno.com

OSE Immunotherapeutics SA is a France-based biotechnology company focused on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases. The product portfolio of the company comprises Tedopi, OSE-172, OSE-703, FR104 and OSE-127.

41GF Score

Get the complete analysis for ORPOF

Dividends per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.43

Price

$3.34

GF Value

View ORPOF Analysis

See Dividends per Share data for all stocks →